[11,12]), alginate/hydroxyapatite (AL) scaffolds functionalized with fibronectin (FN) or incorporating bioactive glass (BG) have previously been shown to enhance biocompatibility when tested with the human osteosarcoma cell line (MG-63). The gene discussed is FN1; the disease is osteosarcoma.